These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34607724)
1. HLA-B*15 predicts survival in Egyptian patients with COVID-19. Abdelhafiz AS; Ali A; Fouda MA; Sayed DM; Kamel MM; Kamal LM; Khalil MA; Bakry RM Hum Immunol; 2022 Jan; 83(1):10-16. PubMed ID: 34607724 [TBL] [Abstract][Full Text] [Related]
2. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2. Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS; Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158 [TBL] [Abstract][Full Text] [Related]
3. Association between human leukocyte antigen alleles and COVID-19 disease severity. Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M J Infect Public Health; 2024 Sep; 17(9):102498. PubMed ID: 39173558 [TBL] [Abstract][Full Text] [Related]
4. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience. Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L Front Immunol; 2020; 11():605688. PubMed ID: 33343579 [TBL] [Abstract][Full Text] [Related]
5. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002 [TBL] [Abstract][Full Text] [Related]
6. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity. Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F Front Immunol; 2022; 13():769900. PubMed ID: 35185875 [TBL] [Abstract][Full Text] [Related]
7. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19. Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915 [TBL] [Abstract][Full Text] [Related]
9. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592 [TBL] [Abstract][Full Text] [Related]
10. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19. Shkurnikov M; Nersisyan S; Jankevic T; Galatenko A; Gordeev I; Vechorko V; Tonevitsky A Front Immunol; 2021; 12():641900. PubMed ID: 33732261 [TBL] [Abstract][Full Text] [Related]
11. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463 [TBL] [Abstract][Full Text] [Related]
12. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study. Niño-Ramírez JE; Alcoceba M; Gutiérrez-Zufiaurre MN; Marcos M; Gil-Etayo FJ; Bartol-Sánchez MR; Eiros R; Chillón MC; García-Álvarez M; Terradillos-Sánchez P; Presa D; Muñoz JL; López-Bernús A; López-Sánchez E; González-Calle D; Sánchez PL; Compán-Fernández O; González M; García-Sanz R; Boix F HLA; 2024 Aug; 104(2):e15640. PubMed ID: 39148254 [TBL] [Abstract][Full Text] [Related]
13. Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality. Sakuraba A; Haider H; Sato T Viruses; 2020 Nov; 12(11):. PubMed ID: 33233780 [TBL] [Abstract][Full Text] [Related]
14. Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance. Londono J; Santos AM; Rueda JC; Calvo-Paramo E; Burgos-Vargas R; Vargas-Alarcon G; Martinez-Rodriguez N; Arias-Correal S; Muñoz GN; Padilla D; Cuervo F; Reyes-Martinez V; Bernal-Macías S; Villota-Eraso C; Avila-Portillo LM; Romero C; Medina JF RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917832 [TBL] [Abstract][Full Text] [Related]
15. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374 [TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients. Ebrahimi S; Ghasemi-Basir HR; Majzoobi MM; Rasouli-Saravani A; Hajilooi M; Solgi G Hum Immunol; 2021 Oct; 82(10):719-725. PubMed ID: 34294460 [TBL] [Abstract][Full Text] [Related]
17. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure. Khor SS; Omae Y; Nishida N; Sugiyama M; Kinoshita N; Suzuki T; Suzuki M; Suzuki S; Izumi S; Hojo M; Ohmagari N; Mizokami M; Tokunaga K Front Immunol; 2021; 12():658570. PubMed ID: 33968060 [TBL] [Abstract][Full Text] [Related]
18. The Interleukin-6 gene variants may protect against SARS-CoV-2 infection and the severity of COVID-19: a case-control study in a Moroccan population. Noureddine R; Baba H; Aqillouch S; Abounouh K; Laazaazia O; Elmessaoudi-Idrissi M; Bahmani FZ; Tanouti IA; Ouladlahsen A; Sarih M; Dehbi H; Ezzikouri S BMC Med Genomics; 2024 May; 17(1):139. PubMed ID: 38783290 [TBL] [Abstract][Full Text] [Related]
19. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population. Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837 [TBL] [Abstract][Full Text] [Related]